Trial Profile
Open, Multicenter Follow-up Trial About Active Group of Phase IIb Clinical Trial of JOINTSTEM in Patients With Degenerative Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors BioStar
- 28 Jan 2021 Status changed from active, no longer recruiting to completed.
- 02 May 2018 New trial record